Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094681710> ?p ?o ?g. }
- W3094681710 endingPage "1722" @default.
- W3094681710 startingPage "1722" @default.
- W3094681710 abstract "Antibody responses that correlated with reduced risk of HIV acquisition in the RV144 efficacy trial were assessed in healthy African volunteers who had been primed three times with HIV-DNA (subtype A, B, C) and then randomized into two groups; group 1 was boosted twice with HIV-MVA (CRF01_AE) and group 2 with the same HIV-MVA coadministered with subtype C envelope (Env) protein (CN54rgp140/GLA-AF). The fine specificity of plasma Env-specific antibody responses was mapped after the final vaccination using linear peptide microarray technology. Binding IgG antibodies to the V1V2 loop in CRF01_AE and subtype C Env and Env-specific IgA antibodies were determined using enzyme-linked immunosorbent assay. Functional antibody-dependent cellular cytotoxicity (ADCC)-mediating antibody responses were measured using luciferase assay. Mapping of linear epitopes within HIV-1 Env demonstrated strong targeting of the V1V2, V3, and the immunodominant region in gp41 in both groups, with additional recognition of two epitopes located in the C2 and C4 regions in group 2. A high frequency of V1V2-specific binding IgG antibody responses was detected to CRF01_AE (77%) and subtype C antigens (65%). In conclusion, coadministration of CN54rgp140/GLA-AF with HIV-MVA did not increase the frequency, breadth, or magnitude of anti-V1V2 responses or ADCC-mediating antibodies induced by boosting with HIV-MVA alone." @default.
- W3094681710 created "2020-11-09" @default.
- W3094681710 creator A5004527390 @default.
- W3094681710 creator A5005601710 @default.
- W3094681710 creator A5016020009 @default.
- W3094681710 creator A5016546294 @default.
- W3094681710 creator A5029733628 @default.
- W3094681710 creator A5030596607 @default.
- W3094681710 creator A5040294618 @default.
- W3094681710 creator A5041279635 @default.
- W3094681710 creator A5045642851 @default.
- W3094681710 creator A5050241874 @default.
- W3094681710 creator A5050612131 @default.
- W3094681710 creator A5053343091 @default.
- W3094681710 creator A5053823377 @default.
- W3094681710 creator A5056145693 @default.
- W3094681710 creator A5056392452 @default.
- W3094681710 creator A5057965152 @default.
- W3094681710 creator A5060884846 @default.
- W3094681710 creator A5061857469 @default.
- W3094681710 creator A5067925206 @default.
- W3094681710 creator A5068489472 @default.
- W3094681710 creator A5073981579 @default.
- W3094681710 creator A5074775871 @default.
- W3094681710 creator A5076820552 @default.
- W3094681710 date "2020-11-04" @default.
- W3094681710 modified "2023-10-01" @default.
- W3094681710 title "Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers" @default.
- W3094681710 cites W1136695336 @default.
- W3094681710 cites W1791659070 @default.
- W3094681710 cites W1966607693 @default.
- W3094681710 cites W1983706520 @default.
- W3094681710 cites W1989580827 @default.
- W3094681710 cites W1991656907 @default.
- W3094681710 cites W2002116074 @default.
- W3094681710 cites W2005816484 @default.
- W3094681710 cites W2008767788 @default.
- W3094681710 cites W2014694744 @default.
- W3094681710 cites W2016262427 @default.
- W3094681710 cites W2021207488 @default.
- W3094681710 cites W2031894834 @default.
- W3094681710 cites W2034587047 @default.
- W3094681710 cites W2035541600 @default.
- W3094681710 cites W2037181410 @default.
- W3094681710 cites W2060119188 @default.
- W3094681710 cites W2065353103 @default.
- W3094681710 cites W2097771941 @default.
- W3094681710 cites W2098781795 @default.
- W3094681710 cites W2107683840 @default.
- W3094681710 cites W2114273761 @default.
- W3094681710 cites W2116971967 @default.
- W3094681710 cites W2120129606 @default.
- W3094681710 cites W2122345805 @default.
- W3094681710 cites W2133956851 @default.
- W3094681710 cites W2143421242 @default.
- W3094681710 cites W2143818994 @default.
- W3094681710 cites W2144699392 @default.
- W3094681710 cites W2151026229 @default.
- W3094681710 cites W2152048324 @default.
- W3094681710 cites W2152640863 @default.
- W3094681710 cites W2153670011 @default.
- W3094681710 cites W2156885603 @default.
- W3094681710 cites W2158266834 @default.
- W3094681710 cites W2161122417 @default.
- W3094681710 cites W2164119431 @default.
- W3094681710 cites W2164147266 @default.
- W3094681710 cites W2169656611 @default.
- W3094681710 cites W2240372320 @default.
- W3094681710 cites W2562192119 @default.
- W3094681710 cites W2603304127 @default.
- W3094681710 cites W2766512135 @default.
- W3094681710 cites W2774336495 @default.
- W3094681710 cites W2902100811 @default.
- W3094681710 cites W2940880353 @default.
- W3094681710 cites W2992363429 @default.
- W3094681710 cites W2999377398 @default.
- W3094681710 cites W3003444067 @default.
- W3094681710 cites W3009078956 @default.
- W3094681710 cites W3022093750 @default.
- W3094681710 cites W819351050 @default.
- W3094681710 doi "https://doi.org/10.3390/microorganisms8111722" @default.
- W3094681710 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7693996" @default.
- W3094681710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33158007" @default.
- W3094681710 hasPublicationYear "2020" @default.
- W3094681710 type Work @default.
- W3094681710 sameAs 3094681710 @default.
- W3094681710 citedByCount "6" @default.
- W3094681710 countsByYear W30946817102020 @default.
- W3094681710 countsByYear W30946817102021 @default.
- W3094681710 countsByYear W30946817102022 @default.
- W3094681710 countsByYear W30946817102023 @default.
- W3094681710 crossrefType "journal-article" @default.
- W3094681710 hasAuthorship W3094681710A5004527390 @default.
- W3094681710 hasAuthorship W3094681710A5005601710 @default.
- W3094681710 hasAuthorship W3094681710A5016020009 @default.
- W3094681710 hasAuthorship W3094681710A5016546294 @default.
- W3094681710 hasAuthorship W3094681710A5029733628 @default.
- W3094681710 hasAuthorship W3094681710A5030596607 @default.